Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HBB | P68871 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | CES2 | O00748 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.35 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1874394 | 0.84 | MAPT (0.38) | L3MBTL1NPC1MAPTHTTALDH1A1 | |
| SCHEMBL6938598 | 0.83 | L3MBTL1 (0.39) | L3MBTL1NPC1MAPTHTTALOX15 | |
| SCHEMBL28014454 | 0.83 | NPC1 (0.42) | L3MBTL1NPC1MAPTHTTALOX15 | |
| 2,4-Dihydroxybenzophenone SCHEMBL10615149 | 0.83 | MEN1 (0.61) | NPC1MAPTHTTALOX15ALDH1A1 | |
| SCHEMBL7851780 | 0.82 | L3MBTL1 (0.41) | L3MBTL1NPC1MAPTHTTALOX15 | |
| SCHEMBL4621722 | 0.81 | NPC1 (0.40) | L3MBTL1NPC1MAPTHTTALOX15 | |
| SCHEMBL28413826 | 0.80 | MCL1 (0.41) | L3MBTL1NPC1ALDH1A1MCL1KMT2A | |
| SCHEMBL9178594 | 0.79 | L3MBTL1 (0.46) | L3MBTL1NPC1MAPTHTTALOX15 | |
| SCHEMBL29091452 | 0.79 | NPC1 (0.40) | L3MBTL1NPC1MAPTHTTALOX15 | |
| SCHEMBL11176223 | 0.79 | AKT1 (0.37) | L3MBTL1NPC1MAPTHTTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0498707-B1 | Process of dyeing keratinous fibers with a mono- or di-hydroxyindole and a non-oxidative aromatic carbonyl derivative and dyeing agent | OREAL (FR) | 1995-08-02 | — | — | EP | claimed |
| EP-0498707-A1 | Process of dyeing keratinous fibers with a mono- or di-hydroxyindole and a non-oxidative aromatic carbonyl derivative and dyeing agent | L'OREAL (FR) | 1992-08-12 | — | — | EP | claimed |
| JP-1287160-A | — | — | None | — | — | JP | disclosed |
| JP-60166305-A | — | — | None | — | — | JP | disclosed |
| CN-122056781-A | Two-part dental sealant, method of administration with a syringe device, and kit | 舒万诺知识产权公司 | 2026-05-19 | — | — | CN | disclosed |
| US-12523664-B2 | Sensor chip and methods thereof | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2026-01-13 | — | — | US | disclosed |
| WO-2025110168-A1 | SILICATE MINERAL AND METHOD FOR PRODUCING SAME | 株式会社スーパーナノデザイン | 2025-05-30 | — | — | WO | disclosed |
| US-20240156691-A1 | TWO-PHASE COMPOSITION | L'OREAL (FR) | 2024-05-16 | — | — | US | disclosed |
| EP-4301316-A1 | TWO-PHASE COMPOSITION | L'OREAL (FR) | 2024-01-10 | — | — | EP | disclosed |
| US-20230355484-A1 | TWO-PHASE COMPOSITION | L'OREAL (FR) | 2023-11-09 | — | — | US | disclosed |
| US-20230355483-A1 | TWO-PHASE COMPOSITION COMPRISING AT LEAST ONE HYDROCARBON OIL AND AT LEAST ONE ESTER OF CITRIC ACID, WHEREIN THE COMPOSITION IS PREFERABLY A CLEANSING COMPOSITION | L'OREAL (FR) | 2023-11-09 | — | — | US | disclosed |
| EP-0174135-A2 | Heat-developable color light-sensitive material | KONICA CORPORATION (JP) | 1986-03-12 | — | — | EP | disclosed |
| JP-S60166305-A | PRODUCTION OF CURED PRODUCT | SHOWA DENKO KK | 1985-08-29 | — | — | JP | disclosed |
| EP-0035392-B1 | LAMINATED MULTILAYER MATERIAL AND ITS USE AS A PACKAGING OR BUILDING MATERIAL | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1983-11-23 | — | — | EP | disclosed |
| US-4397916-A | FOOD PACKAGING, CONSTRUCTION MATERIALS | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1983-08-09 | — | — | US | disclosed |
| EP-0016617-B1 | LAMINATED MULTILAYER STRUCTURE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1983-03-09 | — | — | EP | disclosed |
| US-4370388-A | GRAFTED HIGH DENSITY POLYETHYLENE | MITSUI PETROCHEMICAL INDUSTRIES LTD. (JP) | 1983-01-25 | — | — | US | disclosed |
| EP-0035392-A1 | Laminated multilayer material and its use as a packaging or building material | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1981-09-09 | — | — | EP | disclosed |
| EP-0016617-A1 | Laminated multilayer structure | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1980-10-01 | — | — | EP | disclosed |
| US-4131463-A | Electric recording process of images using electron sensitive layer containing trivalent cobalt complex and compound having conjugated π bond system | FUJI PHOTO FILM CO., LTD. (JP) | 1978-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230355484-A1 | TWO-PHASE COMPOSITION | FFAR2, GK, FFAR1 | L3MBTL1 3407/4885NPC1 2241/4885MAPT 3847/4885 |
| US-20230355483-A1 | TWO-PHASE COMPOSITION COMPRISING AT LEAST ONE HYDROCARBON OIL AND AT LEAST ONE ESTER OF CITRIC ACID, WHEREIN THE COMPOSITION IS PREFERABLY A CLEANSING COMPOSITION | POLG, FFAR2, POLA1 | L3MBTL1 3902/4885NPC1 2076/4885MAPT 3491/4885 |
| US-20240156691-A1 | TWO-PHASE COMPOSITION | FFAR2, DEGS1, FFAR1 | L3MBTL1 2605/4885NPC1 3852/4885MAPT 1919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.